BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 16618397)

  • 1. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota.
    Jess T; Loftus EV; Velayos FS; Harmsen WS; Zinsmeister AR; Smyrk TC; Schleck CD; Tremaine WJ; Melton LJ; Munkholm P; Sandborn WJ
    Gastroenterology; 2006 Apr; 130(4):1039-46. PubMed ID: 16618397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of lymphoma in inflammatory bowel disease.
    Loftus EV; Tremaine WJ; Habermann TM; Harmsen WS; Zinsmeister AR; Sandborn WJ
    Am J Gastroenterol; 2000 Sep; 95(9):2308-12. PubMed ID: 11007233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer in patients with ulcerative colitis, Crohn's disease and coeliac disease: record linkage study.
    Goldacre MJ; Wotton CJ; Yeates D; Seagroatt V; Jewell D
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):297-304. PubMed ID: 18334873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inflammatory bowel disease and colorectal cancer].
    Hagymási K; Tulassay Z
    Orv Hetil; 2006 Oct; 147(41):1977-82. PubMed ID: 17120688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Colorectal cancer in inflammatory bowel disease].
    Henriksen M; Moum B
    Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2696-9. PubMed ID: 17952155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
    Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
    Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-calculus suppurative cholangitis in Danish patients with inflammatory bowel disease.
    Rasmussen HH; Nørgård B; Olsen ML; Fonager K; Sørensen HT
    Hepatogastroenterology; 2005; 52(61):115-8. PubMed ID: 15783009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies.
    Jess T; Gamborg M; Matzen P; Munkholm P; Sørensen TI
    Am J Gastroenterol; 2005 Dec; 100(12):2724-9. PubMed ID: 16393226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ulcerative colitis and colorectal cancer. A population-based study.
    Ekbom A; Helmick C; Zack M; Adami HO
    N Engl J Med; 1990 Nov; 323(18):1228-33. PubMed ID: 2215606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease.
    Canavan C; Abrams KR; Mayberry J
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1097-104. PubMed ID: 16611269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early measles virus infection is associated with the development of inflammatory bowel disease.
    Pardi DS; Tremaine WJ; Sandborn WJ; Loftus EV; Poland GA; Harmsen WS; Zinsmeister AR; Melton LJ
    Am J Gastroenterol; 2000 Jun; 95(6):1480-5. PubMed ID: 10894583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.
    Jess T; Loftus EV; Velayos FS; Winther KV; Tremaine WJ; Zinsmeister AR; Scott Harmsen W; Langholz E; Binder V; Munkholm P; Sandborn WJ
    Am J Gastroenterol; 2007 Apr; 102(4):829-36. PubMed ID: 17222314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients.
    Maykel JA; Hagerman G; Mellgren AF; Li SY; Alavi K; Baxter NN; Madoff RD
    Dis Colon Rectum; 2006 Jul; 49(7):950-7. PubMed ID: 16729218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognosis of inflammatory bowel disease.
    Sales DJ; Kirsner JB
    Arch Intern Med; 1983 Feb; 143(2):294-9. PubMed ID: 6824395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study.
    Limburg PJ; Vierkant RA; Fredericksen ZS; Leibson CL; Rizza RA; Gupta AK; Ahlquist DA; Melton LJ; Sellers TA; Cerhan JR
    Am J Gastroenterol; 2006 Aug; 101(8):1872-9. PubMed ID: 16790032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of cancer in patients with Crohn's disease.
    von Roon AC; Reese G; Teare J; Constantinides V; Darzi AW; Tekkis PP
    Dis Colon Rectum; 2007 Jun; 50(6):839-55. PubMed ID: 17308939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer and pediatric inflammatory bowel disease.
    Kayton ML
    Semin Pediatr Surg; 2007 Aug; 16(3):205-13. PubMed ID: 17602977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
    Lindström L; Lapidus A; Ost A; Bergquist A
    Dis Colon Rectum; 2011 Nov; 54(11):1392-7. PubMed ID: 21979184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.